Fetal growth restriction (FGR) happens when the foetus does not cope with its intrauterine potency for growing and maturation as an outcome of defect in placental function.There is an increased risk of long-term health problems and perinatal morbidity and mortality in fetuses with FGR.These include adult-onset endocrine or cardiovascular disorders, as well as compromised neurological and cognitive development. Five to ten percent of pregnancies end in FGR.The great percentage in relation to the gestational age is used to define FGR in clinical practice. An assessed foetalsize that is lower the 3rd percentage is known as FGR, according to the World Health Organization (WHO). On the other hand, FGR is defined by (ACOG) as an An assessed foetalsize that is lower the tenth percentage for pregnancy, and this is often linked to deficiency of placenta.

AIM OF THE WORK:
To assess the effect of maternal Dexamethasone administration on Doppler indices of fetuses suffering from FGR.